Why the study?
What is the optimal surgical management strategy for patients with combined coronary artery disease and malignancy?
What is the optimal surgical management strategy for patients with combined coronary artery disease and malignancy?
This review outlines considerations for the timing and technique of surgical revascularization in patients with concurrent coronary artery disease and malignancy.
Provides framework for individualized decisions in CAD-malignancy; leaves open need for prospective trials to guide practice.
Surgical management of patients with combined coronary artery disease and malignancy remains a challenge. In this review the time of surgical intervention, whether to treat the malignancy or the coronary artery disease first, and which bypass technique should be used during myocardial revascularization are reviewed to determine the most optimal strategy to manage patients who require coronary surgical revascularization and present with an underlying malignancy.
No takes yet. Share an insight, caveat, or question.
Ahmad K. Darwazah (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: